SCHEMBL397148

SCHEMBL397148

CC=CCC1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3931959 0.97 NOS2 (0.46)
SCHEMBL818573 0.97 NOS2 (0.46)
SCHEMBL10597549 0.97 NOS2 (0.46)
SCHEMBL818572 0.97 NOS2 (0.46)
SCHEMBL10597539 0.97 NOS2 (0.46)
SCHEMBL3932444 0.94
SCHEMBL19595018 0.88
SCHEMBL3935708 0.88
SCHEMBL6996772 0.88
SCHEMBL8530783 0.85 CYP1A2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 360 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4666619-A TER- OR TETRAPOLYMER, THICKENERS EXXON RESEARCH & ENGINEERING CO. (US) 1987-05-19 US claimed
EP-0188103-A2 An ethylene polymer useful as a lubricating oil viscosity modifier EXXON RESEARCH AND ENGINEERING COMPANY (US) 1986-07-23 EP claimed
EP-4377315-A1 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF Children's Hospital Medical Center (US) 2024-06-05 EP disclosed
US-20240124468-A1 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF CHILDREN'S HOSPITAL MEDICAL CENTER 2024-04-18 US disclosed
WO-2024076614-A2 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2024-04-11 WO disclosed
CN-112480937-B Liquid crystal compound, liquid crystal composition, liquid crystal display element, and liquid crystal display 石家庄诚志永华显示材料有限公司 2024-04-02 CN disclosed
WO-2024030908-A1 MULTI-CYCLIC IRAK1 AND IRAK4 INHIBITING COMPOUNDS AND USES THEREOF CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2024-02-08 WO disclosed
US-11865110-B2 Thrombin inhibitors, formulations, and uses thereof VERSEON INTERNATIONAL CORPORATION (US) 2024-01-09 US disclosed
CN-113004906-B Liquid crystal compound and application thereof 石家庄诚志永华显示材料有限公司 2024-01-05 CN disclosed
WO-2023250431-A2 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2023-12-28 WO disclosed
WO-2023245123-A2 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2023-12-21 WO disclosed
WO-1999015529-A1 MODULES OF PROTEIN TYROSINE PHOSPHATASES (PTPases) NOVO NORDISK A/S (DK) 1999-04-01 WO disclosed
WO-1999002155-A1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS ONTOGEN CORPORATION (US) 1999-01-21 WO disclosed
US-5840721-A INCREASE SENSITIVITY OF MULTIDRUG RESISTANT TUMOR CELLS TO ANTICANCER AGENTS ONTOGEN CORPORATION (US) 1998-11-24 US disclosed
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
CN-1188471-A 1,4-disubstituted piepridine derivatives BANYU PHARMA CO LTD (JP) 1998-07-22 CN disclosed
WO-1998027065-A1 MODULATORS OF PROTEINS WITH PHOSPHOTYROSINE RECOGNITION UNITS ONTOGEN CORPORATION (US) 1998-06-25 WO disclosed
US-5753687-A ACRYLATED ARYLIMIDAZOLE DERIVATIVES ONTOGEN CORPORATION (US) 1998-05-19 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed
US-3993684-A PHOTOSENSITIVE ACRYLIC ESTER POLYMERS WESTERN LITHO PLATE & SUPPLY CO. (US) 1976-11-23 US disclosed